2025-03-01
2024-05-19
| Summary | |
|---|---|
| Cancer Type | Lung Cancer |
| Grade | NA |
| Stage | NA |
| Ethnicity | Asian |
| Gender | F |
| Age | 69 |
| Pathology Diagnosis | Adenocarcinoma, poorly differentiated, malignant cells diffuse infiltrated in lung with massive necrosis. No malignant cells adjacet to stump. Regional LN: hilum of lung LN (3/3), the eleventh group LN (0/2),the fivth group LN (0/1), the seventh group LN (0/3). IHC results: Syn(-), CHgA(+/-), TTF-1(+++), SPB(-), CK7(++), EGFR(-), ER(-), ER-(++), CK20(-), RRM-1(++), CEA(+++), CK34BE12(+), Tubulin b3(+), ERCC-1(++), Ki-67(50%+), CD34(blood vessel +). |
| Biopsy Site | primary |
| Treatment History | NA |
| Pathology QC | Poorly differentiated adenocarcinoma (P3, P6). |
| Special Features | NA |
| Mouse Strain | Balb/c nu |
| TMA | TMA-HP-LU-016 |
| Viral Status in PDX | NA |
| Available In | CB_CN |
| RNA Seq | P4 |
| Exome Seq | P1 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy